StemCell Therapy

At the end of the latest market close, Unity Biotechnology Inc. (UBX) was valued at $11.98. In that particular session, Stock kicked-off at the price of $12.20 while reaching the peak value of $12.29 and lowest value recorded on the day was $11.31. The stock current value is $11.78.

Recently in News on August 4, 2020, UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital. UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it has entered into a $80 million debt facility with Hercules Capital [NYSE: HTGC]. You can read further details here

Unity Biotechnology Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the companys stock is recorded $15.44 on 08/10/20, with the lowest value was $4.62 for the same time period, recorded on 03/13/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Unity Biotechnology Inc. shares are logging -23.70% during the 52-week period from high price, and 154.98% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $4.62 and $15.44.

The companys shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1416746 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Unity Biotechnology Inc. (UBX) recorded performance in the market was 63.38%, having the revenues showcasing 70.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 626.46M, as it employees total of 100 workers.

During the last month, 0 analysts gave the Unity Biotechnology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.76, with a change in the price was noted +6.65. In a similar fashion, Unity Biotechnology Inc. posted a movement of +129.63% for the period of last 100 days, recording 418,635 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity The total Debt to Equity ratio for UBX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of Unity Biotechnology Inc. in the period of last 50 days is set at 55.31%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.94%. In the last 20 days, the companys Stochastic %K was 63.33% and its Stochastic %D was recorded 74.31%.

If we look into the earlier routines of Unity Biotechnology Inc., multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be pessimistic, given the fact the metric is recording 63.38%. Additionally, trading for the stock in the period of the last six months notably improved by 83.20%, alongside a boost of 76.35% for the period of the last 12 months. The shares increased approximately by 15.15% in the 7-day charts and went down by 59.40% in the period of the last 30 days. Common stock shares were driven by 70.48% during last recorded quarter.

Go here to read the rest:
Unity Biotechnology Inc. (UBX) market price of $11.78 offers the impression of an exciting value play - The InvestChronicle

This entry was posted on August 12, 2020 at 8:48 pm and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |